icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
zd7A8MdqZkDg4mC8
Listen
